MERCK'S ANTI-VIRAL COVID-19 PILL TO BE MADE IN GTA

Dec 06, 2021

By Bob Komsic

Share on
While awaiting Health Canada approval, Merck has announced it intends to produce its antiviral COVID-19 pill in Whitby.
The drug company has invested $19-million to increase production at Thermo Fisher Scientific’s facility in the east-end of the GTA.
The drug, one of the first treatment for non-hospitalized COVID patients, works by block the enzyme essential for viral replication.
Merck’s preliminary clinical trial showed the pill reduced the risk of hospitalization or death by 50% in patients with mild or moderate COVID.
However, an updated news release from the drug company late last month says the reduced risk was actually lower, at 30%.
The federal government announced last week Canada had a signed agreement to buy 500,000 courses of the drug with an option to purchase another 500,000 if Health Canada approves.
Zoomer Kids
You Don't Have To Be A Zoomer To Love Zoomer Radio.
Check out what the Kids have to say!
Join Our Fan Club
Coverage Area
Downtown Toronto
96.7FM
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
AM740
ZoomerRadio Logo

Recently Played: